Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Chloroquine sulfate Plaquenil fda package insert Plaquenil for ivf Plaquenil does increase liver enyzmes Today, Plaquenil and other antimalarials are also used to treat and help prevent symptoms caused by certain autoimmune diseases such as rheumatoid arthritis RA, systemic lupus erythematosus, and discoid lupus, even though these diseases are not caused by malaria parasites. Plaquenil belongs in a class of medications known as disease-modifying. Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. Plaquenil hydroxychloroquine belongs to a group of medicines called quinolines. Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. Plaquenil autoimmune neutropenia HYDROXYCHLOROQUINE - ORAL Plaquenil side effects., Hydroxychloroquine Plaquenil 25 μm chloroquine diphosphateHydroxychloroquine scarring alopeciaDejar de tomar plaquenil WebMD discusses the symptoms, causes, and treatment of neutropenia, an immune system condition that may lead to infections. Neutropenia Causes, Symptoms, and Treatment. Plaquenil Uses, Dosage & Side Effects -. Complications With Valtrex Healthfully. Introduction Hydroxychloroquine is a Aminoquinoline derivative which is widely used for treatment of malaria, rheumatoid arthritis and lupus besides many other autoimmune diseases. Though neutropenia is listed as a potential side effect, there is no reported case in the literature. We present a very rare presentation of hydroxychloroquine. The results of their study, however, suggested an autoimmune mechanism for neutropenia in patients with SLE.9. Rustagi et al,11 in a study of 18 patients with SLE, suggested complement-activating antineutrophil IgG autoantibodies existed in SLE and their presence correlated with neutropenia. The neutrophil-binding IgG was 2–3 times higher. This article is a review of different management strategies for the hematological manifestations of systemic lupus erythematosus SLE, the strategies include immunosuppressive drugs, some noval therapies and B-cell depletion for refractory thrombocytopenia in patients with SLE and in antiphospholipid antibody syndrome associated with SLE.